A
Alpha Tau Medical Ltd. (DRTS)
NCM – Real Time Price. Currency in USD
9.88
-0.46 (-4.45%)
At close: May 12, 2026, 4:00 PM EDT
9.90
+0.02 (0.20%)
After-hours: May 12, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
9.88
-0.46 (-4.45%)
At close: May 12, 2026, 4:00 PM EDT
9.90
+0.02 (0.20%)
After-hours: May 12, 2026, 7:59 PM EDT
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
| Name | Position |
|---|---|
| Dr. Robert B. Den M.D. | Chief Medical Officer & Member of Scientific Advisory Board |
| Mr. Amnon Gat | Chief Operations Officer |
| Mr. Raphi Levy | Chief Financial Officer |
| Mr. Ronen Segal | Chief Technology Officer |
| Mr. Uzi Sofer | CEO & Chairman |
| Ms. Rebecca Becker | Vice President of legal |
| Ms. Yael Zeiger | Corporate Controller |
| Prof. Yona Keisari | Chief Scientific Officer & Member of Scientific Advisory board |
| Date | Type | Document |
|---|---|---|
| 2026-05-08 | 6-K | ea028978301-6k_alphatau.htm |
| 2026-05-07 | 6-K | ea0289554-6k_alphatau.htm |
| 2026-05-05 | 6-K | ea0289093-6k_alphatau.htm |
| 2026-05-04 | 6-K | ea0288785-6k_alphatau.htm |
| 2026-04-28 | F-3 | ea0285710-f3_alpha.htm |
| 2026-04-27 | 6-K | ea0287690-6k_alphatau.htm |
| 2026-04-23 | 6-K | ea0287451-6k_alphatau.htm |
| 2026-03-31 | 6-K | ea0284322-6k_alpha.htm |
| 2026-03-09 | 20-F | ea0279271-20f_alpha.htm |
| 2026-02-24 | 6-K | ea0278144-6k_alpha.htm |